Jam

Wingspire Equipment Finance has provided over $130 million in equipment financing to six portfolio companies of a major private equity sponsor, including a $40+ million transaction. This partnership highlights the growing trend of private equity firms seeking specialized equipment financing to optimize capital structures. Spanning energy, healthcare, and aerospace, the financing enables these companies to boost capacity and modernize infrastructure. Wingspire’s speed, scale, and alignment with private equity risk profiles are key differentiators, facilitating efficient funding and allowing firms to focus on core competencies.

NervGen Pharma announced positive Q3 2025 results highlighting progress in the CONNECT SCI study, where NVG-291 showed clinically meaningful improvements in spinal cord injury patients versus placebo. 75% of the NVG-291 group reported global improvement compared to 33% in the placebo arm. The FDA confirmed potential regulatory pathways for NVG-291, with an End-of-Phase 2 meeting planned for early 2026. A $10.05M private placement was completed. Cash reserves stood at $11.4M. Preclinical data showed promise in hearing loss and nerve injury models.

Qudian Inc. reported its Q3 2025 unaudited financial results, revealing a sharp 84.5% drop in revenue to RMB8.5 million due to the last-mile delivery business phase-out. However, net income attributable to shareholders surged to RMB409.9 million, driven by increased investment income and gains on derivative instruments. The company maintains a strong cash position and continues its share repurchase program. Qudian’s future hinges on successful diversification and strategic capital allocation.

Lake Victoria Gold (LVGLF) announced its Q3 2025 exploration update detailing Bulyanhulu’s progress on six licenses acquired under the 2021 APA. Highlights include the completion of 94 line-km of GAIP surveying and the commencement of aircore drilling at the Enze target (19 holes, 419m). Diamond and RC drilling are planned for Q4 2025. Project expenditures total US$6.7M of a proposed US$9M. LVG could receive up to US$45M in contingent payments and engaged Atrium Research for services at $3,500/month for 9 months, pending TSXV approval.

BW LPG announced it will harmonize dividend payment dates for shares traded on the Oslo and New York Stock Exchanges, aiming to expedite payments for Oslo-registered shareholders. While payment dates are synchronized, the USD-denominated dividend policy remains unchanged, with NOK conversion for Oslo shareholders announced with quarterly results. This procedural update reflects BW LPG’s focus on shareholder value and operational efficiency amidst shifts in the LPG market. BW LPG is the world’s leading owner and operator of LPG vessels.

The 2025 ISG Paragon Awards™ Asia recognized organizations strategically deploying AI, digital technology, and innovative operating models for business success. Winners, selected by an independent panel, were announced at a Singapore gala. Awards highlighted excellence in areas like Best-in-Class delivery (Avanade with Country Foods), Innovation (Tech Mahindra with Mahindra Auto and Farm), Transformation (TCS with Plaza Premium Group), and AI Pacesetter (Avanade with Alexandra Group). iCompaz and Temasek Holdings received Honorary Distinction for Partnership Excellence. The awards reflect the growing importance of the Asia Pacific region in leveraging AI and other technologies.

Bayer’s Phase III OCEANIC-STROKE trial showed that asundexian, a Factor XIa inhibitor, significantly reduced the risk of ischemic stroke recurrence when combined with antiplatelet therapy, compared to placebo. Crucially, asundexian did not increase major bleeding events. This marks the first successful Phase III trial for a Factor XIa inhibitor. Bayer plans to pursue marketing authorization globally. Detailed results will be presented at an upcoming scientific congress. Asundexian has received FDA Fast Track designation.

Freedom Holding Corp. released its 2025 Sustainability Report, detailing ESG investments of 27.87 billion tenge ($57.6 million USD) across its operating regions. Key areas include education/technology (AI facility, Fintech Bootcamp), sports/healthy lifestyles (football complex), social/infrastructure projects (flood relief, theater reconstruction), and environmental projects (COP29, Aral Sea restoration). The company emphasizes youth development, gender balance, and strategic achievements like the UN SDG Regional Office in Almaty. Freedom Holding provides financial services in 21 countries and is listed on NASDAQ, KASE, and AIX.

Trinity One Metals (ARJNF) announced board changes on November 22, 2025. Robert Payment, the current CFO and corporate secretary, was appointed as a director. David Wheeler resigned as director, effective immediately. The board thanked Wheeler for his contributions. The TSX Venture Exchange disclaims responsibility for the release’s accuracy.

Zhibao Technology (ZBAO) received a Nasdaq deficiency letter for failing to file its Form 20-F for the fiscal year ended June 30, 2025, putting it at risk of non-compliance with Nasdaq Listing Rule 5250(c)(1). The notice doesn’t immediately affect the stock listing. Zhibao has 60 days to submit a compliance plan, potentially receiving an extension until May 13, 2026, if accepted. The company intends to file the report and submit a plan, with the option to appeal to a Nasdaq Hearings Panel if the plan is rejected.